Research graph
References from Malignancy risk and mortality after lung transplantation: A single-institution experience over 31 years. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Post-transplant malignancy in solid organ transplant recipients in Ireland, The Irish Transplant Cancer Group
2019 · External reference
Spectrum of cancer risk among US solid organ transplant recipients
10.1001/jama.2011.1592 · 2011 · External reference
Risk factors for de novo malignancy following lung transplantation
10.1111/ajt.13925 · 2017 · External reference
Incidence of malignancies in heart and/or lung transplant recipients: a single-institution experience
10.1016/j.healun.2007.05.019 · 2007 · External reference
Cancer risk and mortality after solid organ transplantation: a population-based 30-year cohort study in Finland
10.1002/ijc.33934 · 2022 · External reference
Cancer risk in heart or lung transplant recipients: a comprehensive analysis of 21 prospective cohorts
10.1002/cam4.3525 · 2020 · External reference
Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients
10.1111/j.1600-6143.2012.04302.x · 2013 · External reference
Keratinocyte cancer mortality in kidney transplant recipients
10.1097/tp.0000000000003827 · 2022 · External reference
Aggressive behavior of nonmelanotic skin cancers in solid organ transplant recipients
10.1097/tp.0b013e3181ec7228 · 2010 · External reference
High-level interface for survival analysis and associated plots
2022 · External reference
10.1007/978-3-319-24277-4_9
10.1007/978-3-319-24277-4_9 · External reference
Unresolved reference
External reference
Incidence and prevalence of non-melanoma skin cancer in Australia: a systematic review
10.1111/ajd.12282 · 2015 · External reference
Unresolved reference
2008 · External reference
De novo cancer-related death in Australian liver and cardiothoracic transplant recipients
10.1111/ajt.12192 · 2013 · External reference
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult lung and heart–lung transplantation report—2019; focus theme: donor and recipient size match
10.1016/j.healun.2019.08.001 · 2019 · External reference
Mortality after lung transplantation: a single-centre cohort analysis
10.1111/tri.13540 · 2020 · External reference
Unresolved reference
External reference
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-eighth adult lung transplantation report—2021; focus on recipient characteristics
10.1016/j.healun.2021.07.021 · 2021 · External reference
Post-transplant lymphoproliferative disease in lung transplantation: a nested case-control study
10.1111/ctr.12983 · 2017 · External reference
Posttransplant lymphoproliferative disease after lung transplantation
10.1155/2013/430209 · 2013 · External reference
Incidence and outcome of post-transplant lymphoproliferative disorders in lung transplant patients: analysis of ISHLT Registry
10.1016/j.healun.2020.06.010 · 2020 · External reference
Dermatological disease in Australian heart and lung transplant recipients
10.1159/000510055 · 2021 · External reference
Nonmelanoma skin cancer frequency and risk factors in Australian heart and lung transplant recipients
10.1001/jamadermatol.2018.4789 · 2019 · External reference
High prevalence of skin cancers and actinic keratoses in lung transplant recipients
10.1016/j.healun.2017.11.016 · 2018 · External reference
Comparison of skin cancers in liver and renal transplant recipients: results of a prospective study in an Australian tertiary referral centre
10.1111/ajd.12759 · 2018 · External reference
Prevalence of skin cancer and related skin tumors in high-risk kidney and liver transplant recipients in Queensland, Australia
10.1016/j.jid.2016.02.804 · 2016 · External reference
Incidence and risk factors for skin cancer following lung transplantation
10.1016/j.jaad.2014.09.010 · 2015 · External reference
Risk factors for developing nonmelanoma skin cancer after lung transplantation
10.1155/2019/7089482 · 2019 · External reference
Patients’ sun practices, perceptions of skin cancer and their risk of skin cancer in rural Australia
10.1002/hpja.253 · 2020 · External reference
Unresolved reference
External reference
Pre-transplant malignancy: an analysis of outcomes after thoracic organ transplantation
10.1016/j.healun.2012.11.003 · 2013 · External reference
Outcomes of solid organ transplant recipients with preexisting malignancies in remission: a systematic review and meta-analysis
10.1097/tp.0000000000001192 · 2017 · External reference
Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation
10.1016/j.healun.2021.07.005 · 2021 · External reference
10.1111/ajt.13593
10.1111/ajt.13593 · 2016 · External reference
The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients
10.1016/j.jaad.2012.01.010 · 2012 · External reference
Pre-transplant malignancy is associated with increased risk of de novo malignancy post-lung transplantation
10.1016/j.rmed.2022.106855 · 2022 · External reference
Pretransplant solid organ malignancy and organ transplant candidacy: a consensus expert opinion statement
10.1111/ajt.16318 · 2021 · External reference
Determining clinical thresholds for donor HLA eplet compatibility to predict best outcomes following lung transplantation
2022 · External reference
Immune checkpoint inhibitors in transplantation-a case series and comprehensive review of current knowledge
10.1097/tp.0000000000003292 · 2021 · External reference
Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial
10.1097/tp.0b013e3182247ae2 · 2011 · External reference
Everolimus based immunosuppression strategies in adult lung transplant recipients: calcineurin inhibitor minimization versus calcineurin inhibitor elimination
10.3389/ti.2023.10704 · 2023 · External reference
Lung cancer in recipients after lung transplant: single-centre experience and literature review
2022 · External reference
Posttransplantation lymphoproliferative disorder in lung transplant recipients: A 15-year single institution experience
10.1097/tp.0b013e31829b0718 · 2013 · External reference
Incidence and mortality by cancer in patients after lung transplantation in a Brazilian institution
10.1016/j.transproceed.2017.01.068 · 2017 · External reference
Nonmelanoma skin cancer frequency and risk factors in Australian heart and lung transplant recipients
10.1001/jamadermatol.2018.4789 · 2019 · External reference
